Professor Emeritus in the Holden Comprehensive Cancer Center (HCCC) at the University of Iowa. He was the director for both Urology Research and Prostate Cancer Research Programs and served as the Associate Director for Research Infrastructure in the HCCC. Dr. Lubaroff has over 40 years of experience with research on prostate cancer immunology and 20 years of investigating vaccine immunotherapy that includes both preclinical testing and Phase I and Phase II clinical trials in prostate cancer patients.
Founder and Chief Scientific Officer (CSO)
Vast experience in the entrepreneurial business. He is currently director of Clients Services at ALPS Corporation and has a Private Consulting Company to market and increase exposure of young companies. He received his MBA from the Henry B. Tippie College of Business at University of Iowa and earned his B.S. in Business and Music at Northwestern University.
Chief Operating Officer (COO)
Mark Ehrmann JD
Attorney at Quarles and Brady with significant experience representing emerging growth companies. Mr. Ehrmann has earned numerous professional recognitions among them named as the Best Lawyers 2014 Mergers & Acquisitions “Lawyer of the Year” in Madison, WI.
legal and patents
Ohana Advisory Board
George Weiner MD
University of Iowa is the Director of the Holden Comprehensive Cancer Center at the University of Iowa, C.E. Block Chair of Cancer Research, Professor of Internal Medicine.
Univesity of Iowa
Gail Bishop PhD
Serves as Director of the Center for Immunology and Immune-Based Diseases.
University of Iowa
Wendy Maury PhD
Professor of Microbiology and member of the Center for Gene Therapy of Cystic Fibrosis and other Genetic Diseases, the Center for Immunology and Immune-based Diseases, and the Helen C. Levitt Center for Viral Pathogenesis, HCCC.
University of Iowa
Joel Harris BA
Past VP of Operations at Harrisvaccines, Inc. and Associate Director of Marketing at Merck Animal Health.
Adam Koppes JD
Investment Manager at Iowa Farm Bureau Federation. In his position Mr. Koppes is responsible for coordinating investments into new and existing companies in the State of Iowa. He is also the former Vice President and CFO of Harrisvaccines, Inc. with whom Ohana Vaccines’ collaboration initiated the studies that are the basis of our initial goals. Thus, he has extensive experience with the vaccine industry and potential investors.